Evidence mapPaperPMID 41497485Full record

ArticleJournal of diabetes research2025

Genetic Characterization of MODY in Iranian Families Using Multigenerational-Based Whole-Exome Sequencing Approach.

Fateme Sefid, Masoud Dehghan Tezerjani, Samira Asadollahi, Seyed Ali Madani, Tayebeh Pardal, Maryam Imani, Zahra Salmani, Masoud Rahmanian, Hossein Hozhabri, Seyed Mehdi Kalantar and 1 more

Abstract read
In one paragraph

Article in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fateme SefidDepartment of Medical Genetics, Shahid Sadoughi University of Medical Science, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0003-0867-9305
Masoud Dehghan TezerjaniResearch Center for Health Technology Assessment and Medical Informatics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0002-2586-1224
Samira AsadollahiDiabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0002-6712-0504
Seyed Ali MadaniResearch Development Center, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0002-2725-8576
Tayebeh PardalDiabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0001-7777-7991
Maryam ImaniReproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0003-4311-8810
Zahra SalmaniDiabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0009-0007-4847-6453
Masoud RahmanianDiabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0001-8199-7081
Hossein HozhabriDepartment of Experimental Medicine, Sapienza University, Rome, Italy, uniroma1.it.ORCID https://orcid.org/0000-0003-0106-8050
Seyed Mehdi KalantarAbortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0001-6471-0157
Mohammad Yahya Vahidi MehrjardiDiabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ssu.ac.ir.ORCID https://orcid.org/0000-0003-0535-1590

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Maturity-onset diabetes of the young (MODY), a common type of monogenic diabetes caused by a pathogenic variant in a single gene, is characterized by starting at an early age, autosomal dominant inheritance, and decreased secretion of insulin. Despite its clinical importance, its accurate diagnosis is challenging, and it is often misdiagnosed as other types of diabetes. Therefore, understanding the genetic basis of MODY can improve diagnostic accuracy. Methods: We initially performed genetic counseling for 2964 probands who visited the Yazd Diabetes Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, between 2018 and 2022. Clinical assessments and pedigree analyses were conducted for the accurate clinical diagnosis and management of diabetes. Among these, 11 probands with unknown types of diabetes who met specific criteria, including an inheritance pattern across at least three generations, at least seven affected individuals, and probands being under age 55, were selected for whole-exome sequencing (WES). Finally, variants were verified by Sanger sequencing, pedigree analysis, and segregation analysis. Results: WES analysis detected pathogenic variants in two families, which confirmed MODY. Family 202 had a novel missense variant (GCK: c.484G > C; p.Gly162Arg; NM_000162.5). In Family 105, an extremely rare pathogenic frameshift variant (HNF1A: c.1136_1137del; p.Pro379ArgfsTer39; NM_000545.8) was identified. The segregation analyses of these variants also revealed that the variants largely co-segregated with the diabetes phenotype in their respective families. Conclusion: This study clearly demonstrates the effectiveness of WES for the accurate identification of MODY subtypes in Iranian families. Moreover, these findings emphasize the need for further genetic screening programs in Iran to enhance MODY diagnosis, personalized treatment, and family genetic counseling.

Indexed as

Diabetes Mellitus, Type 2Germinal Center KinasesAdolescentAdultExome SequencingFemaleGenetic CounselingGenetic Predisposition to DiseaseHepatocyte Nuclear Factor 1-alphaHumansIranMaleMiddle AgedMutation, MissensePedigreePhenotypeGerminal Center KinasesHepatocyte Nuclear Factor 1-alphaMAP4K2 protein, humanexome sequencingGCKHNF1AMODY

Identifiers

PMID41497485
PMCPMC12767221

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.